Omer Karaca1, Huseyin U Pınar2, Enver Arpacı3, Rafi Dogan2, Oya Y Cok4, Ali Ahiskalioglu5. 1. Department of Anaesthesiology, Baskent University School of Medicine, Konya, Turkey. Electronic address: dromerkaraca@hotmail.com. 2. Department of Anaesthesiology, Baskent University School of Medicine, Konya, Turkey. 3. Department of Plastic and Reconstructive Surgery, Baskent University School of Medicine, Konya, Turkey. 4. Department of Anaesthesiology, Baskent University School of Medicine, Adana, Turkey. 5. Department of Anaesthesiology, Ataturk University School of Medicine, Erzurum, Turkey.
Abstract
PURPOSE: The present study was planned to evaluate the efficacy and safety of ultrasound-guided Pecs I and II blocks for postoperative analgesia after sub-pectoral breast augmentation. METHODS:Fifty-four adult female patients undergoing breast augmentation were randomly divided into two groups: the control group (Group C, n=27) who were not subjected to block treatment and Pecs group (Group P, n=27) who received Pecs I (bupivacain 0.25%, 10mL) and Pecs II (bupivacain 0.25%, 20mL) block. Patient-controlled fentanyl analgesia was used for postoperative pain relief in both groups, and the patients were observed for the presence of any block-related complications. RESULTS: The 24-h fentanyl consumption was smaller in Group P [mean±SD, 378.7±54.0μg and 115.7±98.1μg, respectively; P<0.001]. VAS scores in Group P were significantly lower at the time of admission to the post-anaesthetic care unit and at 1, 2, 4, 8, 12, and 24h (P<0.001). The rates of nausea and vomiting were higher in Group C than in Group P (9 vs 2, P=0.018). Hospital stay duration was shorter in Group P than in Group C (24.4±1.2h vs 27.0±3.1h, P<0.001). No block-related complications were recorded. CONCLUSIONS: Combine used of Pecs I and II blocks provide superior postoperative analgesia in patients undergoing breast augmentation and shortens hospital stay.
RCT Entities:
PURPOSE: The present study was planned to evaluate the efficacy and safety of ultrasound-guided Pecs I and II blocks for postoperative analgesia after sub-pectoral breast augmentation. METHODS: Fifty-four adult female patients undergoing breast augmentation were randomly divided into two groups: the control group (Group C, n=27) who were not subjected to block treatment and Pecs group (Group P, n=27) who received Pecs I (bupivacain 0.25%, 10mL) and Pecs II (bupivacain 0.25%, 20mL) block. Patient-controlled fentanylanalgesia was used for postoperative pain relief in both groups, and the patients were observed for the presence of any block-related complications. RESULTS: The 24-h fentanyl consumption was smaller in Group P [mean±SD, 378.7±54.0μg and 115.7±98.1μg, respectively; P<0.001]. VAS scores in Group P were significantly lower at the time of admission to the post-anaesthetic care unit and at 1, 2, 4, 8, 12, and 24h (P<0.001). The rates of nausea and vomiting were higher in Group C than in Group P (9 vs 2, P=0.018). Hospital stay duration was shorter in Group P than in Group C (24.4±1.2h vs 27.0±3.1h, P<0.001). No block-related complications were recorded. CONCLUSIONS: Combine used of Pecs I and II blocks provide superior postoperative analgesia in patients undergoing breast augmentation and shortens hospital stay.
Authors: Ge Luo; Jianjun Zhu; Huadong Ni; Qinghe Zhou; Yaping Lu; Qihong Shen; Yibing Yao; Qiuli He; Jie Fu; Ming Yao Journal: Biomed Res Int Date: 2021-04-16 Impact factor: 3.411
Authors: Marek Szamborski; Jarosław Janc; Joanna Rosińczuk; Jędrzej Jerzy Janc; Patrycja Leśnik; Lidia Łysenko Journal: Int J Environ Res Public Health Date: 2022-07-17 Impact factor: 4.614
Authors: Alberto A Uribe; Tristan E Weaver; Marco Echeverria-Villalobos; Luis Periel; Joshua Pasek; Juan Fiorda-Diaz; Marilly Palettas; Roman J Skoracki; Stephen J Poteet; Jarrett A Heard Journal: Front Med (Lausanne) Date: 2022-08-15